Scholarly Index
Stéphane Dalle
Hospices Civils de Lyon; 24,257 total citations; 686 total publications; best world rank #31
Hospices Civils de Lyon
24,257Total citations
686Total publications
73H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Cutaneous lymphoproliferative disorders research | Lifetime | 59 | FR 6 | 99.14 |
| Cancer Immunotherapy and Biomarkers | Lifetime | 356 | FR 31 | 99.16 |
| CAR-T cell therapy research | Lifetime | 381 | FR 19 | 98.87 |
| Cutaneous Melanoma Detection and Management | Lifetime | 142 | FR 8 | 98.77 |
| Nonmelanoma Skin Cancer Studies | Lifetime | 221 | FR 10 | 97.58 |
| Melanoma and MAPK Pathways | Lifetime | 219 | FR 10 | 97.61 |
| Nail Diseases and Treatments | Lifetime | 306 | FR 15 | 97.45 |
| Infectious Diseases and Mycology | Lifetime | 669 | FR 32 | 92.86 |
| Cancer Immunotherapy and Biomarkers | 2021-2025 | 177 | FR 14 | 99.31 |
| CAR-T cell therapy research | 2021-2025 | 124 | FR 10 | 99.13 |
| Immunotherapy and Immune Responses | 2021-2025 | 107 | FR 8 | 98.18 |
| Cutaneous lymphoproliferative disorders research | 2021-2025 | 31 | FR 3 | 97.56 |
| Melanoma and MAPK Pathways | 2021-2025 | 51 | FR 4 | 96.95 |
| Pancreatic function and diabetes | 2021-2025 | 592 | FR 11 | 91.01 |
| Cutaneous Melanoma Detection and Management | 2021-2025 | 551 | FR 14 | 87.02 |
| T-cell and Retrovirus Studies | 2021-2025 | 176 | FR 8 | 86.39 |
| Nail Diseases and Treatments | 2021-2025 | 392 | FR 21 | 83.08 |